CLOs on the Move

Ion Beam Applications

www.iba-worldwide.com

 
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The Company is the worldwide technology leader in the field of proton therapy, the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room systems. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1200 people worldwide, IBA ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

OneShare Health

OneShare Health is a medical cost-sharing ministry providing a unique, affordable, ACA-exempt path to healthcare. OneShare Health is not insurance. With origins in the Anabaptist faith and a chaplain on staff, we are a Health Care Sharing Ministry that welcomes and unites those who agree with our core biblical principles and Statement of Beliefs relating to life, health and caring for others.

Oj Medtech Inc

Oj Medtech Inc is a Bay Shore, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Mental Health Association - Winnipeg Region

Canadian Mental Health Association - Winnipeg Region is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.

Nursing Resources

Nursing Resources is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.